August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Eric Singhi: Can’t-miss Oncology Brothers’ LIVE event at WCLC24
Aug 19, 2024, 10:15

Eric Singhi: Can’t-miss Oncology Brothers’ LIVE event at WCLC24

Eric Singhi shared a post on X by Oncology Brothers, adding:

“Can’t-miss Oncology Brothers’ LIVE event at WCLC24 — Join us as we discuss all things practice-changing for patients with lung cancer!

Register here.”

Quoting Oncology Brothers’s post:

“3 weeks to go! Excited to discuss how the data from WCLC24 will change/reinforce our clinical practice at the Advancements in Oncology!

In Person, Date: 9/8/24

Time: 6-8PM.”

Amy Moore shared these posts, adding:

“Just registered! Amazing lineup! WCLC24 – what do all these developments mean for patients? Can’t wait to hear from this all-star panel!”

Image

Sources: Eric Singhi/X, Oncology Brothers/X and Amy Moore/X

Dr. Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.

Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families.

Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.

Dr. Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.